Looking for volunteers
Efficacy of RUS GA Surgical Navigation for Robot-assisted Distal Gastrectomy in Gastric Cancer Patients
NCT06639490 · Yonsei University · Updated 17 June 2025
- What is being tested
- RUS GA; standard treatment
- For
- Gastric Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 90 years. About 330 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 3 Dec 2024, ends 22 March 2027. Registered 15 Oct 2024.
- Results
- None posted yet.
In the researchers' words
This investigator-initiated, randomized superiority clinical trial aims to demonstrate the clinical effectiveness of RUS GA Surgical Navigation, an endoscopic imaging treatment planning software, in patients undergoing robotic-assisted distal gastric cancer surgery. The trial will compare the experimental group using RUS GA with a control group, aiming to show an 8.7% reduction in total surgery duration. The study will involve global multicenter patient recruitment and evaluate the clinical safety and feasibility of the software, which has been shown to be reliable in previous studies. * Investigational Medical Device: RUS GA (Endoscopic Imaging Treatment Planning Software, E04010.01) * Clinical Trial duration: 30 months from IRB approval -Target number of subjects: Total of 330 participants
Sites
- Department of Surgery, Yonsei University College of MedicineSeoul, South Korea